The defect you didn't see, is the recall you didn't plan for!
Every drug-coated stent that leaves your line looks perfect, until the one you didn't inspect closely enough comes back as a complaint.
Coating uniformity isn't a cosmetic detail. On a drug-coated stent, an uneven coat, a missed patch, or a hairline defect can change how the drug releases in the body. By the time that shows up, it's not a manufacturing problem anymore—it's a patient safety problem, a regulatory problem, and a reputation problem, all at once.
The challenge most manufacturing teams face isn't a lack of care. It's a lack of coverage. Manual or partial inspection methods can only look at what's directly in front of them. A stent is a 360-degree object, coating flaws can hide on the side you didn't rotate to, in the few seconds you didn't have time to double-check, or in a batch too large to inspect thoroughly under deadline pressure.
There's a second, quieter problem sitting right behind the first one: documentation. Even when a defect is caught, can you prove it was caught, and prove the rest of the batch wasn't affected? In an industry where 21 CFR Part 11 compliance isn't optional, "we checked it" isn't good enough. You need image-based, retrievable evidence for every stent, every time.
This is exactly the gap Stentspect DC was built to close. It's a non-contact visual documentation system designed specifically for drug-coated stents, capturing high-resolution, panoramic images across almost a full 360-degree view, so no side of the stent goes unchecked. Each stent can be scanned in under 90 seconds, with dimensional measurements up to 55mm length and 5mm diameter, and every image is stored and retrievable for future reference or audit, with CAD comparison available for teams that need it.
The bigger shift isn't just "better inspection." It's peace of mind, knowing that what leaves your facility has been seen, measured, and documented, not assumed to be fine.
If your team is still relying on partial checks or inconsistent documentation for drug-coated stents, it may be worth asking: what would it take to see the whole picture, every time?